Interactions between leptin and the human sympathetic nervous system

Hypertension

Volumn 41, Issue 5, 2003, Pages 1072-1079

  Eikelis, Nina ^b   Schlaich, Markus ^b   Aggarwal, Anuradha ^b   Kaye, David ^b   Esler, Murray ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b NONE

Author keywords

Aging; Autonomic nervous system; Heart failure; Hypertension, essential; Leptin; Nervous system, sympathetic renal; Obesity

Indexed keywords

LEPTIN; NORADRENALIN;

ADRENALIN RELEASE; ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ADULT; AGED; AGING; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD LEVEL; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HEART FAILURE; HORMONE RELEASE; HUMAN; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; MALE; NEGATIVE FEEDBACK; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; SYMPATHETIC TONE;

ADULT; AGING; ANTIHYPERTENSIVE AGENTS; AUTONOMIC NERVOUS SYSTEM DISEASES; CLONIDINE; EPINEPHRINE; FEMALE; HUMANS; HYPERTENSION; INFUSIONS, INTRAVENOUS; LEPTIN; MALE; MIDDLE AGED; NITROPRUSSIDE; NOREPINEPHRINE; OBESITY; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0038334588     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000066289.17754.49     Document Type: Article

References (40)

1. Ahima RS, Flier JS. Leptin. Annu Rev Physiol. 2000;62:413-437.
2. Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau JP, Bortoluzzi MN, Moizo L, Lehy T, Guerre-Millo M, Le Marchand-Brustel Y, Lewin MJ. The stomach is a source of leptin. Nature. 1998;394:790-793.
3. Hassink SG, de Lancey E, Sheslow DV, Smith-Kirwin SM,. O'Connor DM, Considine RV, Opentanova I, Dostal K, Spear ML, Leef K, Ash M, Spitzer AR, Funanage VL. Placental leptin: an important new growth factor in intrauterine and neonatal development? Pediatrics. 1997;100: E1-E6.
4. Esler M, Vaz M, Collier G, Nestel P, Jennings G, Kaye D, Seals D, Lambert G. Leptin in human plasma is derived in part from the brain, and cleared by the kidneys. Lancet. 1998;351:879.
5. Morash B, Li A, Murphy PR, Wilkinson M, Ur E. Leptin gene expression in the brain and pituitary gland. Endocrinology. 1999;140:5995-5998.
6. Woods AJ, Stock MJ. Leptin activation in hypothalamus. Nature. 1996; 381:745.
7. Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes. 1997;46:2040-2043.
8. Elmquist JK, Ahima RS, Maratos-Flier E, Flier JS, Saper CB. Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology. 1997;138:839-842.
9. Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL. Sympathetic and cardiorenal actions of leptin. Hypertension. 1997;30:619-623.
10. Hardie LJ, Guilhot N, Trayhurn P. Regulation of leptin production in cultured mature white adipocytes. Horm Metab Res. 1996;28:685-689.
11. Trayhurn P, Duncan JS, Hoggard N, Rayner DV. Regulation of leptin production: a dominant role for the sympathetic nervous system? Proc Nutr Soc. 1998;57:413-419.
12. Evans BA, Agar L, Summers RJ. The role of the sympathetic nervous system in the regulation of leptin synthesis in C57BL/6 mice. FEBS Lett. 1999;444:149-154.
13. Donahoo WT, Jensen DR, Yost TJ, Eckel RH. Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion. J Clin Endocrinol Metab. 1997;82:4139-4143.
14. Elmquist JK, Maratos-Flier E, Saper CB, Flier JS. Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci. 1998;1:445-450.
15. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation. 1997;96:3423-3429.
16. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, Wiesner GH, Brunner-La Rocca HP, Esler MD. Neural mechanisms in human obesity-related hypertension. J Hypertens. 1999;17:1125-1133.
17. Meyer C, Robson D, Rackovsky N, Nadkarni V, Gerich J. Role of the kidney in human leptin metabolism. Am J Physiol. 1997;273:E903-E907.
18. Taira N, Yabuuchi Y, Yamashita S. Profile of β-adrenoceptors in femoral, superior mesenteric and renal vascular beds of dogs. Br J Pharmacol. 1977;59:577-583.
19. Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol. 2000;35:S1-S7.
20. Esler M, Jackman G, Bobik A, Kelleher D, Jennings G, Leonard P, Skews H, Korner P. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci. 1979;25:1461-1470.
21. Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation. 1994;90:234-240.
22. Goldstein DS, Holmes C, Cannon RO 3rd, Eisenhofer G, Kopin IJ. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med. 1997; 336:696-702.
23. Seals DR, Esler MD. Human ageing and the sympathoadrenal system. J Physiol. 2000;528:407-417.
24. Carulli L, Ferrari S, Bertolini M, Tagliafico E, Del Rio G. Regulation of ob gene expression: evidence for epinephrine-induced suppression in human obesity. J Clin Endocrinol Metab. 1999;84:3309-3312.
25. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990;70:963-985.
26. Medvedev OS, Esler MD, Angus JA, Cox HS, Eisenhofer G. Simultaneous determination of plasma noradrenaline and adrenaline kinetics: responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit. Naunyn Schmiedebergs Arch Pharmacol. 1990;341:192-199.
27. Womersley J, Durnin JVGA. A comparison of the skinfold method with extent of "overweight" and various weight-height relationships in the assessment of obesity. Br J Nutr. 1977;38:271-284.
28. Narkiewicz K, Somers VK, Mos L, Kato M, Accurso V, Palatini P. An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. J Hypertens. 1999;17:245-249.
29. Henriksen JH, Holst JJ, Moller S, Andersen UB, Bendtsen F, Jensen G. Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin. Clin Sci (Colch). 2000; 99:527-534.
30. Murdoch DR, Rooney E, Dargie HJ, Shapiro D, Morton JJ, McMurray JJ. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure. Heart. 1999;82:352-356.
31. Leyva F, Anker SD, Egerer K, Stevenson JC, Kox WJ, Coats AJ. Hyperleptinaemia in chronic heart failure: relationships with insulin. Eur Heart J. 1998;19:1547-1551.
32. Richartz BM, Lotze U, Krack A, Gastmann A, Kuthe F, Figulla HR. Leptin: a parameter for metabolic changes in heart failure. Z Kardiol. 2001;90:280-285.
33. Cryer PE. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med. 1980;303:436-444.
34. Bartness TJ, Bamshad M. Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am J Physiol. 1998;275:R1399-R1411.
35. Morrison SF. Differential regulation of sympathetic outflows to vasoconstrictor and thermoregulatory effectors. Ann N Y Acad Sci. 2001;940:286-298.
36. Fogteloo AJ, Meinders AE, Pijl H, Kroon AA, Frolich M, De Leeuw PW. Renal clearance of endogenous leptin in hypertensive humans with or without renal artery stenosis. Am J Physiol Endocrinol Metab. 2001;281: EA00-EA04.
37. Matsumura K, Abe I, Tsuchihashi T, Fujishima M. Central effects of leptin on cardiovascular and neurohormonal responses in conscious rabbits. Am J Physiol Regul Integr Comp Physiol. 2000;278: R1314-R1320.
38. Landsberg L. Hyperinsulinemia: possible role in obesity-induced hypertension. Hypertension. 1992;19:I-61-I-66.
39. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation. 1998;98:772-776.
40. Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension. 1998;31:64-67.